These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical applications of interleukin-2. von Rohr A; Thatcher N Prog Growth Factor Res; 1992; 4(3):229-46. PubMed ID: 1307490 [TBL] [Abstract][Full Text] [Related]
8. The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer. Yannelli JR J Immunol Methods; 1991 May; 139(1):1-16. PubMed ID: 2040807 [No Abstract] [Full Text] [Related]
9. Natural killer cells: immunobiology and clinical prospects. Lotzová E Cancer Invest; 1991; 9(2):173-84. PubMed ID: 1863873 [No Abstract] [Full Text] [Related]
14. Adoptive immunotherapy of urologic tumors. Belldegrun A; Rosenberg SA Cancer Treat Res; 1989; 46():213-33. PubMed ID: 2577191 [No Abstract] [Full Text] [Related]
15. The role of T lymphocytes in the immunotherapy of tumours. Brondz BD; Balashov KE Biomed Sci; 1991; 2(5):441-9. PubMed ID: 1840832 [TBL] [Abstract][Full Text] [Related]
18. [Cellular immunotherapy of cancer]. Kawakami Y Rinsho Ketsueki; 2003 Jun; 44(6):358-67. PubMed ID: 12884813 [No Abstract] [Full Text] [Related]
19. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy. Yannelli JR; Wroblewski JM Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713 [TBL] [Abstract][Full Text] [Related]
20. Development of immunotherapy for the treatment of malignancies refractory to conventional therapies. Kim S; Haas GP; Hillman GG Cytokines Mol Ther; 1996 Mar; 2(1):13-9. PubMed ID: 9384685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]